AdaptHealth Corp. AHCO
Set alert
At close
Pre-market · Nov 3, 7:25 AM ET
- YTD
- -40.66%
- 1 year
- -34.98%
- Open
- 5.81
- Prev close
- 5.81
- Mkt cap
- 788.45M
- Vol
- 3.04M
- Avg vol
- 3.18M
- EPS
- -1.82
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.76
- High
- 6.01
- Forward P/E
- 12.22
- Beta
- 1.45
- Short ratio
- 0.00
- Inst. own
- 106.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 10.55
- 200-d avg
- 10.26
- 1y target
- 13.63
News
-
1 month ago benzinga.com
Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9
Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $10 to $9.
-
1 month ago benzinga.com
AdaptHealth Corp. Appoints Harriss T. Currie CFO, Effective Sept. 9, Succeeding Jason Clemens
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and
-
2 months ago benzinga.com
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $10.
-
2 months ago benzinga.com
RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $8
RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $15 to $8.
-
2 months ago benzinga.com
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $9.
3 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular session. The company's market cap stands at $1.9 million. Adagio Medical Holdings (NASDAQ:ADGM) shares…
3 months ago benzinga.com
Crude Oil Down Over 5%; McDonald's Earnings Top Views
U.S. stocks gain with Nasdaq up more than 2% on Tuesday. Dow up 1.79% to 54,129.35, Nasdaq up 2.22% to 26,490.24, S&P 500 up 1.64% to 7,725.48. Tech shares jump 3.8%, utilities down 0.5%. McDonald's…
-
3 months ago benzinga.com
UPDATE: AdaptHealth Q2 Adj. EPS $0.08 Misses $0.17 Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.17 by 52.94 percent. This is a 20 percent decrease over earnings of $0.10…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. Adagio Medical Holdings…
-
3 months ago benzinga.com
AdaptHealth Lowers FY2026 Sales Guidance from $3.450B-$3.520B to $2.850B-$2.890B vs $3.488B Est
AdaptHealth (NASDAQ:AHCO) lowers FY2026 sales outlook from $3.450 billion-$3.520 billion to $2.850 billion-$2.890 billion vs $3.488 billion estimate.
-
3 months ago benzinga.com
AdaptHealth Q2 EPS $(0.99) Misses $0.18 Estimate, Sales $740.300M Miss $848.627M Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $0.18 by 650 percent. This is a 1090 percent decrease over earnings of $0.10…
3 months ago benzinga.com
This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday
Wall Street analysts upgraded Fortinet, Goldman Sachs, Adaptive Biotechnologies, and Five Below, with positive outlooks and raised price targets.
-
3 months ago benzinga.com
Jefferies Upgrades AdaptHealth to Buy, Raises Price Target to $13
Jefferies analyst Brian Tanquilut upgrades AdaptHealth (NASDAQ:AHCO) from Hold to Buy and raises the price target from $11 to $13.
-
3 months ago benzinga.com
Cardinal Health To Acquire The Diabetes Health Business Of Adapthealth And, In Its Entirety, Strive Medical For ~$360M In Cash
Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology.…
-
3 months ago benzinga.com
AdaptHealth Divests Diabetes Health Business To Cardinal Health For $235M In Cash
Continues the Company's multi-year effort to focus its portfolio on its core sleep, respiratory, and supporting home medical equipment businessesSharpens strategic focus on businesses where the…
3 months ago benzinga.com
AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems
AdaptHealth disclosed a material cyberattack involving patient data and insurance billing passwords while saying operations remain unaffected.
4 months ago benzinga.com
IBM To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all rating changes, see analyst ratings page.
-
4 months ago benzinga.com
Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $15
Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $18 to $15.
4 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals…
-
5 months ago benzinga.com
RBC Capital Maintains Outperform on AdaptHealth, Raises Price Target to $15
RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $13 to $15.
-
6 months ago benzinga.com
Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $16
Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $14 to $16.
-
6 months ago benzinga.com
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $14
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $15 to $14.
-
6 months ago benzinga.com
CORRECTION: AdaptHealth Q1 Adj. EPS $(0.05) Misses $0.02 Estimate, Sales $819.799M Beat $796.621M Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.02 by 350 percent. This is unchanged from the same period last year. The…
-
6 months ago benzinga.com
AdaptHealth Raises FY2026 Sales Guidance from $3.440B-$3.510B to $3.450B-$3.520B vs $3.463B Est
AdaptHealth (NASDAQ:AHCO) raises FY2026 sales outlook from $3.440 billion-$3.510 billion to $3.450 billion-$3.520 billion vs $3.463 billion estimate.
-
6 months ago benzinga.com
Truist Securities Maintains Buy on AdaptHealth, Raises Price Target to $14
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $13 to $14.
-
8 months ago benzinga.com
Leerink Partners Maintains Outperform on AdaptHealth, Lowers Price Target to $12
Leerink Partners analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $13 to $12.
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
8 months ago benzinga.com
AdaptHealth Q4 Earnings Report: What Investors Need to Know
AdaptHealth Q4 Earnings Report: What Investors Need to Know
8 months ago benzinga.com
AdaptHealth Earnings Report: Q4 Overview
AdaptHealth Earnings Report: Q4 Overview
-
8 months ago benzinga.com
AdaptHealth Q4 Adj. EPS $0.19 Misses $0.35 Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.35 by 45.71 percent. This is a 44.12 percent decrease over earnings of $0.34…
-
8 months ago benzinga.com
AdaptHealth Sees FY2026 Sales $3.440B-$3.510B vs $3.441B Est
Guidance for Fiscal Year 2026While fourth quarter 2025 Adjusted EBITDA was impacted by a legal settlement expense of $14.5 million and over $10 million of strategic investments to accelerate…
-
8 months ago benzinga.com
AdaptHealth Q4 Sales $846.289M Beat $831.610M Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly sales of $846.289 million which beat the analyst consensus estimate of $831.610 million by 1.77 percent. This is a 1.21 percent decrease over sales of…
-
8 months ago benzinga.com
Earnings Scheduled For February 24, 2026
Earnings Scheduled For February 24, 2026
8 months ago benzinga.com
Exploring AdaptHealth's Earnings Expectations
Exploring AdaptHealth's Earnings Expectations
-
12 months ago benzinga.com
Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $15
Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $14 to $15.
-
12 months ago benzinga.com
AdaptHealth Affirms FY2025 Sales Guidance of $3.180B-$3.260B vs $3.225B Est
AdaptHealth (NASDAQ:AHCO) affirms FY2025 sales outlook from $3.180 billion-$3.260 billion to $3.180 billion-$3.260 billion vs $3.225 billion estimate.
-
12 months ago benzinga.com
AdaptHealth Q3 EPS $0.16 Misses $0.23 Estimate, Sales $820.314M Beat $799.311M Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.23 by 31.33 percent. This is a 5.88 percent decrease over earnings of $0.17…
12 months ago benzinga.com
Earnings Scheduled For November 4, 2025
Earnings Scheduled For November 4, 2025
-
1 year ago benzinga.com
10 Health Care Stocks Whale Activity In Today's Session
10 Health Care Stocks Whale Activity In Today's Session
-
1 year ago benzinga.com
AdaptHealth Narrows FY2025 Sales Guidance from $3.150B-$3.290B to $3.180B-$3.260B vs $3.252B Est
Financial OutlookThe Company is updating previous financial guidance for fiscal year 2025, as follows:Net revenue of $3.18 billion to $3.26 billion, from $3.15 billion to $3.29 billionAdjusted EBITDA…
-
1 year ago benzinga.com
AdaptHealth Closes Disposition Of Certain Infusion Assets In Wellness At Home Segment; Uses Sale Proceeds To Pay Down $65M In Debt
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and…
-
1 year ago benzinga.com
Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session
-
1 year ago benzinga.com
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $13
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $13.
-
1 year ago benzinga.com
RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $13
RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $14 to $13.
-
1 year ago benzinga.com
AdaptHealth Lowers FY2025 Sales Guidance From $3.22B-$3.36B To $3.18B-$3.32B Vs $3.27B Est; Sees Adjusted EBITDA Of $665M To $705M (Prior $670M To $710M)
Financial OutlookThe Company is updating previous financial guidance for fiscal year 2025 to account for the disposition of certain incontinence assets, as follows:Net revenue of $3.18 billion to…
-
1 year ago benzinga.com
AdaptHealth Q1 EPS $(0.05) Misses $0.04 Estimate, Sales $777.88M Beat $764.77M Estimate
AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.04 by 225 percent. This is a 266.67 percent decrease over earnings of $0.03…
-
1 year ago benzinga.com
Baird Maintains Outperform on AdaptHealth, Raises Price Target to $16
Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $14 to $16.